Bank Julius Baer & Co. Ltd, Zurich Oramed Pharmaceuticals Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$8.19 - $13.89 $2,948 - $5,000	-360 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$12.98 - $29.75 $254,927 - $584,290	-19,640 Reduced 98.2%	360 $5,000
Q3 2021 Nov 12, 2021	BUY	$12.13 - $23.82 $242,600 - $476,400	20,000 New	20,000 $440,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.